Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

The increase in Hb concentration

Outcome Time Frame:

Day 28th or later

Safety Issue:

No

Principal Investigator

Yoshiharu Ishikura

Investigator Role:

Study Director

Investigator Affiliation:

Chugai Pharmaceutical

Authority:

Japan: Ministry of Health, Labor and Welfare

Study ID:

EPO308JP

NCT ID:

NCT00144495

Start Date:

February 2004

Completion Date:

May 2005

Related Keywords:

• Chemotherapy Induced Anemia
• Anemia